Detalles de la búsqueda
1.
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
Lancet Oncol
; 22(12): 1669-1680, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34741822
2.
Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis.
Diabetologia
; 64(6): 1332-1341, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33693987
3.
Acute soluble fibre supplementation has no impact on reducing post-prandial glucose excursions in adults with cystic fibrosis and glucose intolerance.
Ann Endocrinol (Paris)
; 84(6): 767-772, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36764386
4.
Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry.
JAMA Oncol
; 8(1): 114-122, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34817562
5.
Impact of 1h oral glucose tolerance test on the clinical status of adult cystic fibrosis patients over a 4-year period.
PLoS One
; 16(3): e0246897, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33735186
6.
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study.
Eur J Cancer
; 150: 190-202, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33932726
7.
Dyslipidemia is not associated with the development of glucose intolerance or diabetes in cystic fibrosis.
J Cyst Fibros
; 19(5): 704-711, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32327389
8.
Overweight, obesity and significant weight gain in adult patients with cystic fibrosis association with lung function and cardiometabolic risk factors.
Clin Nutr
; 39(9): 2910-2916, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31982192
9.
The main mechanism associated with progression of glucose intolerance in older patients with cystic fibrosis is insulin resistance and not reduced insulin secretion capacity.
J Cyst Fibros
; 18(4): 551-556, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30711385
10.
Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis.
PLoS One
; 14(7): e0219855, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31318914
Resultados
1 -
10
de 10
1
Próxima >
>>